Sage Journals: Discover world-class research

Retricted access

Research article

First published 2006-06

Interferon beta-1b (Betaseron®/Betaferon®) is well tolerated at a dose of 500 mg: interferon dose escalation assessment of safety (IDEAS)

M H Gottesman, S Friedman-Urevich

Multiple Sclerosis Journal

Retricted access

Other

First published 2007-5

Clinical relevance of anti-drug antibodies with interferon beta-1b therapy in multiple sclerosis

M. Cantillon, I. Antonijevic

Multiple Sclerosis Journal

Free access

Research article

First published 2006-1

Safety and Tolerability of a ‘Refrigeration-free’ Formulation of Interferon Beta-1b - Results of a Double-blind,Multicentre,Comparative Study in Patients with Relapsing-Remitting or Secondary Progressive Multiple Sclerosis

K Baum, Mannitol Formulation Study Group

Journal of International Medical Research

Retricted access

Research article

First published 2016-03

An Albumin-Free Formulation for Escherichia coli -Derived Interferon Beta-1b with Decreased Immunogenicity in Immune Tolerant Mice

Mohadeseh Haji Abdolvahab, Ahmad Fazeli, Mazda Radmalekshahi [...]

Journal of Interferon & Cytokine Research

Retricted access

Review article

First published 2010-10

PEGylated Interferon Beta-1a: Meeting an Unmet Medical Need in the Treatment of Relapsing Multiple Sclerosis

Darren P. Baker, Robert Blake Pepinsky, Margot Brickelmaier [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 2016-04

Immunogenicity of Recombinant Human Interferon Beta-1b in Immune-Tolerant Transgenic Mice Corresponds with the Biophysical Characteristics of Aggregates

Mohadeseh Haji Abdolvahab, Ahmad Fazeli, Andhyk Halim [...]

Journal of Interferon & Cytokine Research

Retricted access

Research article

First published 1998-06

Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis

Peter Rieckmann, Bernd Altenhofen, Antje Riegel [...]

Multiple Sclerosis Journal

Free access

Review article

First published 2014-11

Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome

Mark S. Freedman

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2019-4

Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials

Dorothea Buck, Till FM Andlauer, Wilmar Igl [...]

Multiple Sclerosis Journal

Retricted access

Review article

First published 2009-10

Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode

DS Goodin, D. Bates

Multiple Sclerosis Journal

Search results